Canada Pension Plan Investment Board Eli Lilly & CO Transaction History

Canada Pension Plan Investment Board

$96.3 Billion
Q2 2024

A detailed history of Canada Pension Plan Investment Board transactions in Eli Lilly & CO stock. As of the latest transaction made, Canada Pension Plan Investment Board holds 927,153 shares of LLY stock, worth $839 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares

927,153

Previous 789,735 17.4%

Holding current value

$839 Million

Previous $614 Million 36.63%

% of portfolio

0.87%

Previous 0.66%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$724.87 - $909.04 $99.6 Million - $125 Million	137,418 Added 17.4%	927,153 $839 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $92.3 Million - $123 Million	-155,797 Reduced 16.48%	789,735 $614 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $49.5 Million - $58.4 Million	-94,300 Reduced 9.07%	945,532 $551 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $58.7 Million - $80.9 Million	135,000 Added 14.92%	1,039,832 $559 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $12.2 Million - $16.4 Million	-34,900 Reduced 3.71%	904,832 $424 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $41 Million - $48.2 Million	132,000 Added 16.34%	939,732 $323 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $9.4 Million - $11 Million	-29,240 Reduced 3.49%	807,732 $296 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $19.1 Million - $21.7 Million	-64,303 Reduced 7.13%	836,972 $271 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $10.1 Million - $11.8 Million	-36,160 Reduced 3.86%	901,275 $292 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $136 Million - $168 Million	-577,432 Reduced 38.12%	937,435 $268 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $68.2 Million - $84.7 Million	303,481 Added 25.05%	1,514,867 $418 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $42.6 Million - $52.4 Million	-192,239 Reduced 13.7%	1,211,386 $280 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $53.4 Million - $69 Million	295,518 Added 26.67%	1,403,625 $322 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $50.8 Million - $65.8 Million	309,111 Added 38.69%	1,108,107 $207 Million
Q4 2020 Feb 17, 2021	SELL	$130.46 - $172.63 $13 Million - $17.2 Million	-99,473 Reduced 11.07%	798,996 $135 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $52.9 Million - $61.1 Million	361,500 Added 67.32%	898,469 $133 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $4.7 Million - $5.66 Million	-34,451 Reduced 6.03%	536,969 $88.2 Million
Q1 2020 May 13, 2020	BUY	$119.05 - $147.35 $25.8 Million - $32 Million	217,135 Added 61.29%	571,420 $79.3 Million
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $24.9 Million - $30.8 Million	-232,729 Reduced 39.65%	354,285 $46.6 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $23.1 Million - $25.1 Million	-216,506 Reduced 26.94%	587,014 $65.6 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $38.7 Million - $45.2 Million	349,179 Added 76.85%	803,520 $89 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $199 Million - $234 Million	-1,786,093 Reduced 79.72%	454,341 $59 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $7.69 Million - $9.08 Million	-103,600 Reduced 4.42%	2,240,434 $173 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $14 Million - $15 Million	170,500 Added 7.84%	2,344,034 $198 Million
Q3 2017 Oct 30, 2017	BUY	$77.07 - $85.54 $9.69 Million - $10.7 Million	125,670 Added 6.14%	2,173,534 $186 Million
Q2 2017 Jan 31, 2018	BUY	N/A	741,430 Added 56.75%	2,047,864 $169 Million
Q1 2017 Jan 31, 2018	BUY	N/A	1,306,434	1,306,434 $110 Million

Others Institutions Holding LLY

# of Institutions

3,869

Shares Held

751M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $860B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Canada Pension Plan Investment Board with notifications on news.

Account

Canada Pension Plan Investment Board Eli Lilly & CO Transaction History